LifeMD Inc (LFMD)

NASD · Healthcare · Health Information Services · USA

LifeMD Inc is a micro cap company (market value under $300 million) in the Health Information Services industry.

LifeMD is a direct-to-patient healthcare company offering virtual medical care and pharmacy services through a vertically integrated platform. The company serves patients across primary care, men's and women's health, weight management, and other specialties through three consumer brands: LifeMD, Rex MD, and ShapiroMD. LifeMD generates revenue primarily through subscription-based telehealth services and pharmacy fulfillment across affiliated provider networks nationwide.

From its FY2025 annual report (Form 10-K)

Intrinsic value, DCF valuation, financial health and value investing analysis for the LifeMD Inc stock.

Our verdict on LFMD

Overvalued: intrinsic value $0.09 per share, market price $1.79, margin of safety -1795.7% (as of 2026-11-17).

Its liquidation floor, current assets minus every liability, values the shares at $0.09; the price of $1.79 is 1796% above that value.

ETFs with the most weight in LFMD

17 more funds hold it; the full list is part of the paid plan.

More on LFMD

Browse

Peers in Health Information Services

All 40 Health Information Services stocks

Cheaper than LFMD in Health Information Services

12 more in this industry show a wider margin of safety.

Is LFMD undervalued or overvalued?

LFMD is overvalued (as of the 2026-11-17 close). Its liquidation floor, current assets minus every liability, values the shares at $0.09; the price of $1.79 is 1796% above that value.

What is the intrinsic value of LFMD?

$0.09 per share (as of the 2026-11-17 close), against a market price of $1.79. That is a margin of safety of -1795.7%. The value comes from the one valuation method that applies to this company, recomputed every night after the US close.